Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Hoth Therapeutics ( (HOTH) ) just unveiled an update.
On May 13, 2025, Hoth Therapeutics received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement of $1.00 per share. The company has until November 10, 2025, to regain compliance, with options like a reverse stock split under consideration to meet the Nasdaq listing rules.
The most recent analyst rating on (HOTH) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Hoth Therapeutics stock, see the HOTH Stock Forecast page.
More about Hoth Therapeutics
Hoth Therapeutics, Inc. operates in the biotechnology industry, focusing on developing therapies for dermatological disorders and other unmet medical needs.
Average Trading Volume: 645,782
Technical Sentiment Signal: Sell
Current Market Cap: $11.49M
Find detailed analytics on HOTH stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue